Phenotypic characterization of regulatory T cells populations in maternal blood, cord blood and placenta from diabetic mothers

References

• American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care. 2015;38:8–16.
   Web of Science ®Google Scholar
• Niemeijer-Kanters SD, Dallinga-Thie GM, de Ruijter-Heijstek FC, et al. Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus. Atherosclerosis. 2001;156(1):209–216.
   PubMed Web of Science ®Google Scholar
• Boij R, Mjösberg J, Svensson-Arvelund J, et al. Regulatory T-cell subpopulations in severe or early-onset preeclampsia. Am J Reprod Immunol. 2015;74(4):368–378.
   PubMed Web of Science ®Google Scholar
• King GJ. Comparative placentation in ungulates. J Exp Zool. 1993;266(6):588–602.
   PubMedGoogle Scholar
• Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J Immunol. 2007;178(6):3345–3351.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057–1061.
   PubMed Web of Science ®Google Scholar
• Zenclussen AC. Regulatory T cells in pregnancy. Springer Semin Immunopathol. 2006;28(1):31–39.
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, et al. CD4 + CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245–1253.
   PubMed Web of Science ®Google Scholar
• Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest. 2005;115(11):3276–3284.
   PubMed Web of Science ®Google Scholar
• Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA. 2006;103(17):6659–6664.
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol. 2006;176(8):4622–4631.
   PubMed Web of Science ®Google Scholar
• Hara Cde C, França EL, Fagundes DL, et al. Characterization of natural killer cells and cytokines in maternal placenta and fetus of diabetic mothers. J Immunol Res. 2016;2016:7154524.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35:64–71.
   PubMed Web of Science ®Google Scholar
• Rudge MV, Calderon IM, Ramos MD, et al. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Invest. 2000;50(2):108–112.
   PubMed Web of Science ®Google Scholar
• Calderon IM, Damasceno DC, Amorin RL, et al. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes. Diabetes Res Clin Pract. 2007;78(1):65–71.
   PubMed Web of Science ®Google Scholar
• França EL, Calderon Ide MP, Vieira EL, et al. Transfer of maternal immunity to newborns of diabetic mothers. Clin Dev Immunol. 2012:928187.
   PubMedGoogle Scholar
• Moreli JB, Morceli G, De Luca AK, et al. Influence of maternal hyperglycemia on IL-10 and TNF-α production: the relationship with perinatal outcomes. J Clin Immunol. 2012;32(3):604–610.
   PubMed Web of Science ®Google Scholar
• Gomes Fagundes DL, França EL, da Silva Fernandes RT, et al. Changes in T-cell phenotype and cytokines profile in maternal blood, cord blood and colostrum of diabetic mothers. J Matern Fetal Neonatal Med. 2016;29(6):998–1004.
   PubMed Web of Science ®Google Scholar
• Pietro L, Daher S, Rudge MVC, et al. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta. 2010;31(9):770–780.
   PubMed Web of Science ®Google Scholar
• Wahabi HA, Esmaeil SA, Fayed A, et al. Pre-existing diabetes mellitus and adverse pregnancy outcomes. BMC Res Notes. 2012;5:496.
   PubMedGoogle Scholar
• de Souza EG, Hara CC, Fagundes DL, et al. Maternal-foetal diabetes modifies neonatal Fc receptor expression on human leucocytes. Scand J Immunol. 2016;84(4):237–244.
   PubMed Web of Science ®Google Scholar
• Samstein RM, Josefowicz SZ, Arvey A, et al. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. 2012;150(1):29–38.
   PubMed Web of Science ®Google Scholar
• Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta. 2014;35(4):241–248.
   PubMed Web of Science ®Google Scholar
• Bergmann C, Strauss L, Wang Y, et al. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease. Clin Cancer Res. 2008;14(12):3706–3715.
   PubMed Web of Science ®Google Scholar
• de Leeuw RJ, Kroeger DR, Kost SE, et al. CD25 identifies a subset of CD4 + FoxP3− TIL that are exhausted yet prognostically favorable in human ovarian cancer. Cancer Immunol Res. 2014;3:1–9.
   Web of Science ®Google Scholar
• Lapolla A, Dalfrà MG, Sanzari M, et al. Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine. 2005;31(4):280–287.
   PubMed Web of Science ®Google Scholar
• Schober L, Radnai D, Spratte J, et al. The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus. Clin Exp Immunol. 2014;177(1):76–85.
   PubMed Web of Science ®Google Scholar
• Duriez M, Quillay H, Madec Y, et al. Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation. Front Microbiol. 2014;5:316.
   PubMed Web of Science ®Google Scholar
• Weetman AP. The immunology of pregnancy. Thyroid. 1999;9(7):643–646.
   PubMed Web of Science ®Google Scholar
• Fujimori M, França EL, Morais TC, et al. Cytokine and adipokine are biofactors can act in blood and colostrum of obese mothers. Biofactors. 2017;43(2):243–250.
   PubMed Web of Science ®Google Scholar
• Maedler K, Spinas GA, Lehmann R, et al. Glucose induces beta-cell apoptosis via upregulation of the Fas-receptor in human islets. Diabetes. 2001;50(8):1683–1690.
   PubMed Web of Science ®Google Scholar
• Donath MY, Størling J, Maedler K, et al. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl). 2003;81(8):455–470.
   PubMed Web of Science ®Google Scholar
• Nolsøe RL, Hamid YH, Pociot F, et al. Association of a microsatellite in FASL to type II diabetes and of the FAS-670G > A genotype to insulin resistance. Genes Immun. 2006;7(4):316–321.
   PubMed Web of Science ®Google Scholar
• Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol. 2000;24(3):297–302.
   PubMed Web of Science ®Google Scholar
• Fagundes DLG, França EL, Morceli G, et al. The role of cytokines in the functional activity of phagocytes in blood and colostrum of diabetic mothers. Clin Dev Immunol. 2013;2013:590190.
   PubMedGoogle Scholar
• Schaier M, Seissler N, Schmitt E, et al. DR(high+)CD45RA(–)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients. PLoS One. 2012;7(3):e34208.
   PubMed Web of Science ®Google Scholar